Detalhe da pesquisa
1.
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts.
Blood
; 127(23): 2879-89, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27013443
2.
Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic target.
Blood
; 121(11): 2064-73, 2013 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23321254
3.
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease.
Blood
; 122(23): 3778-83, 2013 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24085765
4.
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Blood
; 121(1): 159-69, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100311
5.
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia.
Blood
; 120(12): 2466-74, 2012 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22786882
6.
Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
Blood
; 120(5): 1130-6, 2012 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674806
7.
Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.
Blood
; 120(5): 1118-29, 2012 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22740449
8.
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Blood
; 120(2): 249-58, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22529287
9.
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Blood
; 118(15): 4188-98, 2011 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21828125
10.
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
Blood
; 118(26): 6920-9, 2011 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031865
11.
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(5): 788-92, 2010 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20442368
12.
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(18): 3622-6, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20656931
13.
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Blood
; 116(25): 5660-9, 2010 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20841507
14.
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
N Engl J Med
; 358(18): 1919-28, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18450603
15.
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Haematologica
; 96(10): 1488-95, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21659357
16.
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele.
Blood
; 112(6): 2508-11, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18617636
17.
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
Blood
; 111(11): 5371-9, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18378853
18.
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.
Blood
; 112(5): 2013-6, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18566324
19.
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
Blood
; 112(10): 4193-201, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18716133
20.
Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations.
J Clin Invest
; 116(10): 2707-16, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16981007